EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Neuropeptides in the Management of Alzheimer’s Disease: From Pathophysiology to Therapeutic Opportunities

Shraddha Tiwari, Shiv Kumar Yadav, Meenakshi Kumari iD, Thakur Dhakal, Nidhi Puranik iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27073206 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Shraddha Tiwari und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, Yeungnam University, Gyeongsan 38541, Republic of Korea. Hauptthemen laut MEDLINE: Alzheimer Disease, Neuropeptides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 180 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by memory decline, cognitive impairment, and behavioral changes, ultimately leading to a loss of independence and reduced quality of life. Although understanding of the molecular basis of AD has advanced, effective disease-modifying therapies remain scarce. Neuropeptides are small protein-like signaling molecules that regulate diverse physiological processes, including mood, memory, and neuronal function. Growing evidence indicates that neuropeptides are promising therapeutic candidates for AD, particularly through modulation of neuroinflammation, synaptic plasticity, and amyloid-beta (Aβ) aggregation. Preclinical AD models show that neuroprotective neuropeptides, such as neuropeptide Y (NPY), vasoactive intestinal peptide (VIP), and pituitary adenylate cyclase-activating peptide (PACAP), exert neuroprotective effects, enhance memory, and attenuate cognitive decline. This review summarizes current research on neuropeptide-based therapies for AD, detailing their molecular mechanisms, therapeutic actions, and the barriers to their clinical translation. We specifically highlight neuropeptides whose clinical potential in AD remains comparatively underrecognized, discuss strategies for optimizing their delivery and overcoming pharmacokinetic limitations, and outline future perspectives for integrating neuropeptide-based interventions into AD therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseNeuropeptidesHumansAnimalsNeuropeptide YAmyloid beta-PeptidesPituitary Adenylate Cyclase-Activating PolypeptideVasoactive Intestinal PeptideNeuroprotective Agents

Stichwörter der Autor:innen

Alzheimer’s diseasecorticotropin-releasing factorneuropeptideneuropeptide Ypituitary adenylate cyclase-activating polypeptidesomatostatinsubstance P

Substanzen

NeuropeptidesNeuropeptide YAmyloid beta-PeptidesPituitary Adenylate Cyclase-Activating PolypeptideVasoactive Intestinal PeptideNeuroprotective Agents

Autor:innen und Institutionen

  • Department of Life Sciences, Yeungnam University, Gyeongsan 38541, Republic of Korea.
  • Department of Botany, Government Lal Bahadur Shastri P.G. College, Sironj 464228, India.
  • Department of Botany, Career Point University, Kota 324003, India.

ORCID-Profile: Meenakshi Kumari, Nidhi Puranik

Zitieren

APA

Tiwari, S., Yadav, S. K., Kumari, M., Dhakal, T., & Puranik, N. (2026). Neuropeptides in the Management of Alzheimer’s Disease: From Pathophysiology to Therapeutic Opportunities. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27073206

Vancouver

Tiwari S, Yadav SK, Kumari M, Dhakal T, Puranik N. Neuropeptides in the Management of Alzheimer’s Disease: From Pathophysiology to Therapeutic Opportunities. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27073206

BibTeX
@article{Tiwari2026,
  author = {Tiwari, Shraddha and Yadav, Shiv Kumar and Kumari, Meenakshi and Dhakal, Thakur and Puranik, Nidhi},
  title = {Neuropeptides in the Management of Alzheimer’s Disease: From Pathophysiology to Therapeutic Opportunities},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27073206}
}
Kostenlos starten →